Fig. 2From: Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRYDistribution of GLA mutations observed in men treated with agalsidase; mutations leading to truncated proteins (MTPs) are shown in bold. The genotype was not available for two antibody-negative menBack to article page